Skip to content

Cerus CERS Change in AP

Change in AP at other companies

CorMedix logo
CorMedixCRMD
$4.94M+2,221%
Haemonetics logo
HaemoneticsHAE
-$6.7M
Protagonist Therapeutics logo
Protagonist TherapeuticsPTGX
$3M+143%
QuidelOrtho Corporation logo
QuidelOrtho CorporationQDEL
-$27.7M-2,031%
ADMA Biologics logo
ADMA BiologicsADMA
-$1.23M-968%
Paysign logo
PaysignPAYS
$17.13M+17.5%

Other financials

Income statement

See full
Revenue$53.7M+24.1%
Operating income-$354.0K+94.0%
Net income-$1.6M+78.7%
EPS (diluted)-$0.01+75.0%

Balance sheet

See full
Cash & equivalents$27.9M+43.0%
Total debt$45.0M-43.3%
Total equity$67.6M+21.7%
Total assets$222.9M+7.8%

Cash flow

See full
Operating cash flow-$3.0M-261%
CapEx$233.0K+108%
Free cash flow-$3.3M-243%

Valuation

See full
Market cap$573.06M+124%
Enterprise value$590.17M+86.7%
P/S2.9×-1.0×

Profitability

See full
Gross margin64%
Operating margin-6.2%-2.1pp
Net margin-9.8%-2.8pp
FCF margin3.5%+1.9pp

Returns & leverage

See full
Return on equity-15.5%-5.6pp
Debt / equity0.7×-0.8×
Current ratio1.6×-0.7×

Where this comes from

Reported directly by Cerus in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInAccountsPayable.

The official record: Cerus’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Cerus's change in ap.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Cerus's change in AP?
Cerus (CERS) reported change in AP of $4.14M in Q1 2026.
How has Cerus's change in AP changed year-over-year?
Cerus's change in AP decreased by 17.8% year-over-year, from $5.04M to $4.14M.
What does change in AP mean?
Increase or decrease in amounts owed to suppliers — a key working capital component affecting operating cash flow.